共 50 条
A Retrospective Analysis of Pregnancy Outcomes after Kidney Transplantation in a Single Center
被引:7
|作者:
Akar, Munire Erman
[1
]
Ozekinci, Murat
[1
]
Sanhal, Cem
[1
]
Kececioglu, Nilgun
[5
]
Mendilcioglu, Inanc
[1
]
Senol, Yesim
[2
]
Dirican, Kerem
[6
]
Kocak, Huseyin
[3
]
Dinckan, Ayhan
[4
]
Suleymanlar, Gultekin
[2
]
机构:
[1] Akdeniz Univ, Sch Med, Dept Obstet & Gynecol, TR-07058 Antalya, Turkey
[2] Akdeniz Univ, Sch Med, Dept Publ Hlth, TR-07058 Antalya, Turkey
[3] Akdeniz Univ, Sch Med, Dept Internal Med, TR-07058 Antalya, Turkey
[4] Akdeniz Univ, Sch Med, Dept Gen Surg, TR-07058 Antalya, Turkey
[5] Akdeniz Univ, Sch Med, Tuncer Karpuzoglu Transplantat Ctr, TR-07058 Antalya, Turkey
[6] Antalya Mem Hosp, Antalya, Turkey
关键词:
Renal transplant recipient;
Immunosuppression;
Pregnancy;
RENAL-TRANSPLANTATION;
THERAPY;
RISK;
REPRODUCTION;
RECIPIENTS;
ISSUES;
D O I:
10.1159/000365815
中图分类号:
R71 [妇产科学];
学科分类号:
100211 ;
摘要:
Background: We reported pregnancy outcomes after kidney transplantation in a single transplant center. Methods: We reviewed the perinatal outcomes of female kidney transplant patients of reproductive age (18-40 years) from 1987 to 2011. Results: A total of 246 patients were reviewed. Of these, 43 women registered a pregnancy following kidney transplantation. The mean patient age was 31.3 +/- 4.2 years (range 24-40). The mean transplant-conception interval was 35.9 +/- 12.6 months (range 24-120); 9 patients had a cadaveric allograft. The human leukocyte antigen match was >= 3/6 for 34 patients. The rate of live births was 29/43 (67.4%), miscarriage 10/43 (23.2%), preterm delivery 7/29 (24.1%), preeclampsia 5/29 (17.2%), and intrauterine growth retardation 2/29 (6.9%). Overall, 3/29 patients (10.3%) received a blood transfusion during pregnancy due to persistent symptomatic anemia, despite iron replacement and erythropoietin therapy; 24 patients (82%) had a cesarean section delivery; 3 patients had kidney rejection during pregnancy, with 2 occurring during the 6th postpartum month. Conclusion: Pregnancy should be considered a high risk in renal transplant recipients, necessitating close follow-up. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:13 / 18
页数:6
相关论文